Severe syndrome of inappropriate antidiuretic hormone secretion with docetaxel treatment in metastatic breast cancer.
作者信息
Langer-Nitsche C, Lück H J, Heilmann M
机构信息
Department of Obstetrics and Gynaecology, University of Hanover Medical School, Germany.
出版信息
Acta Oncol. 2000;39(8):1001. doi: 10.1080/02841860050216007.
PMID:11206991
Abstract
摘要
相似文献
1
Severe syndrome of inappropriate antidiuretic hormone secretion with docetaxel treatment in metastatic breast cancer.
Acta Oncol. 2000;39(8):1001. doi: 10.1080/02841860050216007.
2
Docetaxel. A review of its role in breast cancer treatment.
Am J Clin Oncol. 1997 Aug;20(4):429-32. doi: 10.1097/00000421-199708000-00023.
3
Docetaxel (Taxotere) for advanced breast cancer.
Med Lett Drugs Ther. 1996 Sep 27;38(984):87-8.
4
Paclitaxel and docetaxel. Innovation, but at what cost?
Pharmacoeconomics. 1995 Jul;8(1):1-4. doi: 10.2165/00019053-199508010-00001.
5
Docetaxel.
Br J Hosp Med. 1997;57(4):141-4.
6
Taxoids: new weapons against cancer.
Sci Am. 1996 Jun;274(6):94-8. doi: 10.1038/scientificamerican0696-94.
7
Response to dexamethasone in patients with fluid retention after docetaxel.
Lancet. 1996 May 25;347(9013):1486-7. doi: 10.1016/s0140-6736(96)91723-7.
8
Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence.
Clin Oncol (R Coll Radiol). 2000;12(4):272-3.
9
[Current developments in use of docetaxel (taxotere) in gynecologic oncology].
Med Klin (Munich). 1998 Sep 15;93 Suppl 3:4-15. doi: 10.1007/BF03042002.
10
Fatal herpes simplex virus hepatitis complicating chemotherapy with weekly docetaxel.
Ann Oncol. 2003 Feb;14(2):340. doi: 10.1093/annonc/mdg052.
Zotero 插件